Concepedia

Linda Öster

LÖ

Statistics

Publications

21

Citations

783

H-Index

18

Active since

2001

Affiliations

AstraZeneca (Sweden)(Current)

Uppsala University

University of Liège

Swedish University of Agricultural Sciences

AstraZeneca (Japan)

Linda Öster is an author at AstraZeneca (Sweden) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2001–2022

21

Publications

21

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON et al. · Blood · 2015 · 91 citations · Full text

, , +7

The structural basis of cephalosporin formation in a mononuclear ferrous enzyme

K. Valegård, Anke C. Terwisscha van Scheltinga, Alain Dubus et al. · Nature Structural & Molecular Biology · 2003 · 90 citations · Full text

, , +8

Clavatadine A, A Natural Product with Selective Recognition and Irreversible Inhibition of Factor XIa

Malcolm S. Buchanan, Anthony R. Carroll, Deborah Wessling et al. · Journal of Medicinal Chemistry · 2008 · 79 citations · Full text

, , +17

A class of highly selective inhibitors bind to an active state of PI3Kγ

Gangadhara Gangadhara, Göran Dahl, Thomas Bohnacker et al. · Nature Chemical Biology · 2019 · 68 citations

, , +14

Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors

Nils Pemberton, Mickael Mogemark, Susanne Arlbrandt et al. · Journal of Medicinal Chemistry · 2018 · 45 citations · Full text

, , +13

1–5 of 21